Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000563438 | SCV000662282 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-03-26 | criteria provided, single submitter | clinical testing | The p.I708T variant (also known as c.2123T>C), located in coding exon 13 of the MSH2 gene, results from a T to C substitution at nucleotide position 2123. The isoleucine at codon 708 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Invitae | RCV000629938 | SCV000750894 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-08-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000563438 | SCV000906773 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-06-12 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004000854 | SCV004833532 | uncertain significance | Lynch syndrome | 2023-05-31 | criteria provided, single submitter | clinical testing |